Benzinga | Aug 12, 2021 07:26AM EDT

Apyx Medical Q2 EPS $(0.12) Beats $(0.15) Estimate, Sales $11.20M Beat $8.86M Estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $11.20 million which beat the analyst consensus estimate of $8.86 million by 26.41 percent. This is a 160.71 percent increase over sales of $4.30 million the same period last year.